alloxan has been researched along with Atrial Fibrillation in 6 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We sought to investigate the potential effects of pioglitazone, a PPAR-γ activator, on atrial remodeling and atrial fibrillation (AF) inducibility in diabetic rabbits." | 7.85 | Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. ( Cheng, L; Fu, H; Korantzopoulos, P; Li, G; Li, J; Liu, C; Liu, R; Liu, T; Tse, G; Wang, X, 2017) |
| "Apocynin, a NADPH oxidase inhibitor, prevents AF and attenuates atrial remodeling in alloxan-induced diabetic rabbits." | 7.83 | NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits. ( Fu, H; Korantzopoulos, P; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Yang, Y; Zhang, X; Zhang, Z; Zhao, J, 2016) |
| " We sought to investigate the effects of peroxisome proliferator-activated receptor-γ (PPAR-γ) activator rosiglitazone on atrial structural remodeling and atrial fibrillation (AF) promotion in alloxan-induced diabetic rabbits." | 7.80 | Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. ( Korantzopoulos, P; Li, G; Li, J; Liu, T; Zhao, H, 2014) |
| " We sought to investigate the potential effects of pioglitazone, a PPAR-γ activator, on atrial remodeling and atrial fibrillation (AF) inducibility in diabetic rabbits." | 3.85 | Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. ( Cheng, L; Fu, H; Korantzopoulos, P; Li, G; Li, J; Liu, C; Liu, R; Liu, T; Tse, G; Wang, X, 2017) |
| "Apocynin, a NADPH oxidase inhibitor, prevents AF and attenuates atrial remodeling in alloxan-induced diabetic rabbits." | 3.83 | NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits. ( Fu, H; Korantzopoulos, P; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Yang, Y; Zhang, X; Zhang, Z; Zhao, J, 2016) |
| " We sought to investigate the effects of peroxisome proliferator-activated receptor-γ (PPAR-γ) activator rosiglitazone on atrial structural remodeling and atrial fibrillation (AF) promotion in alloxan-induced diabetic rabbits." | 3.80 | Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. ( Korantzopoulos, P; Li, G; Li, J; Liu, T; Zhao, H, 2014) |
| "The purpose of this study was to investigate the effects of hyperglycemia on atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation (AF) in alloxan-induced diabetic rabbits." | 3.78 | Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. ( Cheng, L; Fu, H; Li, G; Li, J; Liu, C; Liu, T; Yang, W, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, X | 1 |
| Liu, Y | 1 |
| Tu, D | 1 |
| Liu, X | 1 |
| Niu, S | 1 |
| Suo, Y | 1 |
| Liu, T | 6 |
| Li, G | 6 |
| Liu, C | 4 |
| Liu, R | 1 |
| Fu, H | 4 |
| Li, J | 5 |
| Wang, X | 1 |
| Cheng, L | 3 |
| Korantzopoulos, P | 3 |
| Tse, G | 2 |
| Zhao, H | 1 |
| Qiu, J | 1 |
| Zhao, J | 2 |
| Liang, X | 1 |
| Yang, Y | 1 |
| Zhang, Z | 1 |
| Zhang, X | 1 |
| Yang, W | 2 |
6 other studies available for alloxan and Atrial Fibrillation
| Article | Year |
|---|---|
Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Atrial Fibrillation; Atrial Function, Left; Atrial Remod | 2020 |
Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.
Topics: Action Potentials; Alloxan; Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Expe | 2017 |
Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
Topics: Alloxan; Animals; Atrial Fibrillation; Atrial Function, Left; Atrial Remodeling; Biomarkers; Cardiac | 2014 |
NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits.
Topics: Acetophenones; Alloxan; Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experime | 2016 |
Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model.
Topics: Action Potentials; Alloxan; Animals; Anti-Arrhythmia Agents; Antioxidants; Atrial Fibrillation; Atri | 2016 |
Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits.
Topics: Alloxan; Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experimental; Disease M | 2012 |